Skip to main content

Search on the website

Nurse department

Nursing department Our rol The mission of the Institut Bordet Department of Nursing is to provide comprehensive care for patients affected by cancer and to deliver high-quality, adapted and personalised nursing care as part of a multidisciplinary team. The Department also seeks to promote the skills, motivation and empowerment of its nursing staff and carers.Nursing care is delivered according...

Molecular Immunology Laboratory

Molecular Immunology Laboratory (MIU) Overview The Molecular Immunology Laboratory strives to improve our understanding of the immune response in cancer and how it can be manipulated to the benefit of the patients. It investigates lymphocyte activities in several clinical conditions:  First, by studying the organization and cellular state of CD4+ T cells and germinal center B cells infiltratin...

Experimental Haematology Laboratory

Experimental Haematology Laboratory (HEMEXP) Description The Experimental Haematology Laboratory is dedicated to fundamental and applied research in the field of haematology and immunology. It operates in symbiosis with the Institut Bordet Haematology Clinic. One of the Laboratory’s strengths lies in the very tight interaction between researchers, the Haematology cell therapy unit (UTCH) and t...

Laboratory of Oncology and Experimental Surgery (LOCE)

Laboratory of Oncology and Experimental Surgery (LOCE) Description The Laboratory of Oncology and Experimental Surgery (LOCE) is a laboratory at the Institut Bordet recognised by the ULB Faculty of Medicine. It specialises in research into malignant melanoma and pigment cells in general. It combines fundamental research with preclinical and translational research. The LOCE has a self-contained...

Tumour Bank

Tumour Bank Tumour bank How to easily participate in cancer research?  Our rol ...

Administrative Research Management Unit (UGAR)

Administrative Research Management Unit (UGAR) Our role The Institut Bordet Administrative Research Management Unit (UGAR) is a centralised unit for the management of research. It pr...

Clinical Trials Support Unit (CTSU)

Clinical trials support unit (CTSU) Our role The Clinical Trials Support Unit (CTSU) is an operational support unit for academic clinical research into all types of cancer. Certain scientific questions of interest to patients can only be understood by means of academic research. This academic research must comply with all quality standards and legal and regulatory requirements applicable to re...

Information Management Unit (UGI)

Information Management Unit (UGI) Our role The Information Management Unit (UGI) provides support to the clinical departments and management of the Institut Bordet.The UGI carries out 4 particular missions: An epidemiology mission – by developing, managing and operating the hospital Cancer Register and by incorporating into it data from multidisciplinary oncological consultations. In so doing ...

Ethics committee

The Ethics Committee     Our role The Institut Jules Bordet Ethics Committee is an independent body whose role includes: monitoring and advising on ethical aspects of hospital care practices; assisting in decision-making on ethical aspects of individual cases; giving its opinion on all protocols for experimentation on humans prior to implementation.The opinions of the Ethics ...

bordet new

A new building for the Institut Jules Bordet Exclusive images of the new Jules Bordet Institute! Watch the video and discover the major project for the new Jules Bordet Institute. Magnificent images of the construction work on the   80,000 m² dedicated exclusively to cancer are accompanied by explanations on how the project was conceived to combine excellence of patient care with optimal well-being for patients and care staff. ...

Clinical Trials Conduct Unit (CTCU)

Clinical Trials Conduct Unit (CTCU) Our rol The role of the Clinical Trials Conduct Unit (CTCU) is to conduct clinical studies in a professional manner, in compliance with European Directives, regulations and Good Clinical Practice – GCP). These clinical studies are carried out in collaboration with pharmaceutical firms and/or academic partners. The Institut Bordet also implements its own clin...

Clinical Cellular Therapy Research Laboratory (LTCC)

Clinical Cellular Therapy Research Laboratory (LTCC) Description The Institut Bordet Clinical Cellular Therapy Research Laboratory (LTCC) is dedicated to fundamental and translational research in the fields of haematology and immunology cellular therapy. The LTCC’s main objectives concern: study of the interaction between leukaemic cells and their microenvironment; establishment of new prognos...

history bordet

History of the Institut Jules Bordet, a pioneer in cancer research Since it was founded in 1939, the Institut Bordet has always remained loyal to its pioneering role in the fight against cancer. With this complex disease, the lives of patients and caregivers do more than simply cross paths, they become entwined. Here are some of the key dates in the history of the Institut Bordet – an institution that is proud of its past but which always looks resolutely towards the future. Creation of the Institut Jules BordetToday, the Institut Bordet remains Belgium’s only integrated, monospecialist cancer hospital. The European Organisation for Research and Treatment of Cancer (EORTC) is established by Professor TagnonToday, the EORTC includes around 300 institutions which work together to develop the best possible therapeutic str...

Research

Research Since its foundation, the Institut Jules Bordet has always strived to understand the cellular mechanisms involved in cancer and to improve cancer treatments. By collaborating closely with healthcare professionals and doctors from all fields of medicine, researchers at the Institut Bordet are able to offer patients the latest innovations derived from scientific research. «The projects carried out by researchers at the Institut Bordet are exceptional in their cross-disciplinary nature and inventiveness. Driving healthcare forward and exploring all possible research avenues – this is the approach we take at the Institut Bordet. »     Martine Piccart  Research Director How research helps to move cancer treatment forward At the Institut Jules Bordet, research is both clinical and translational. It is a highly organised activity mobilising and involving numerous health professionals, as well as patients. ...

Psycho-oncology

Psycho-oncology clinic Our role The objectives of the Psycho-Oncology Clinic of the Institut Jules Bordet are: the psychological and psychiatric management of the patients and/or those close to them, the development of clinical research projects, healthcare-provider/patient communication training and psycho-oncology training in general. The common objective of the psychiatrists, psychologists,...

Jules Bordet Institute

The Institut Jules Bordet A pioneering centre in Belgium’s fight against cancer “The Institut Jules Bordet is an integrated, multidisciplinary centre, unique in Belgium and which enjoys an international reputation. The hospital is devoted entirely to patients affected by cancer. For more than 75 years, our teams have been offering patients leading-edge diagnostic and therapeutic strategies in the prevention, screening and active treatment of all types of cancer. The Institut Bordet also carries out important research activities which every year lead to major discoveries, as well as providing high-level, specialised university training.” Our missions A new building for the Institut Jules Bordet   ...

Second opinion

Requesting a second opinion “Seeking a second opinion is a patient’s right.”    Dr Dominique de Valeriola, General Medical Director, Institut Jules Bordet Second opinion Every year, many patients request a second opinion from the multidisciplinary team of the Institut Jules Bordet. ...

after cancer

and after cancer ... “As well as follow-up care, our patients are offered many types of support, after treatment too.”  Dr Dominique de Valeriola, General Medical Director, Institut Jules Bordet Medical care after cancer After treatment, when medical examinations show no more sign of cancer, the patient is considered to be in remission. It is then that post-cancer care begins. ...

Cancer Prevention and Screening

Cancer prevention and screening In Europe, 1 man in 3 and 1 woman in 4 will develop cancer before the age of 75. You can reduce and control this risk. So put the odds in your favour!   Dr Jean-Benoît Burrion Head of Prevention & Screening Clinic Primary and secondary ...